Infusion Pumps – Market Insights – Japan
The Japanese general purpose pump market will grow slowly over the forecast period due to a decline in the number of hospitals in the country. Despite this, the Japanese general purpose pump market will continue to generate significant revenues because it is very well established and is therefore driven by replacement sales. Meanwhile, the insulin pump market will grow moderately due to favorable reimbursement changes.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for infusion pumps in Japan across a 10-year period.
Several segments of the general purpose pump market are negatively affected by a decline in hospital beds.
Which segments will be negatively affected?
Will sales revenues of these segments grow despite a decline in hospital beds?
Japanese physicians’ preferences for infusion pumps are dissimilar from those in other Asia Pacific countries.
What types of infusion pumps are most preferred in Japan?
Will physician preferences result in a growing penetration of a certain type of infusion pump over the forecast period?
Companies in this market use strategies that specifically target Japanese hospitals and patients in order to remain successful.
Which companies use such strategies and what do they do to remain successful?
Are all companies able to pursue such strategies?
Table of contents
- Infusion Pumps - Market Insights - Japan
- Abstract
- Infusion Pumps - Japan - 2017
- Executive Summary
- Version History
- Infusion Pump Market
- General Purpose Pump Market
- Insulin Pump Market
- Methodology
- Appendix
Prasad Pallemsetty is a manager within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Clarivate, specializing in the fields of gastroenterology, bariatrics, diabetes, ENT and bronchoscopy, gynecology, and urology. In particular, he has extensive knowledge of endoscopic devices, laparoscopic devices, and minimally invasive procedures. Prasad has attended many international conferences, including ENDOCON 2016 in Mumbai and Diabetes India 2018 in Kolkata, where he gained insight into the latest trends in endoscopic gastroenterology and diabetes treatments, respectively. Prasad holds a Bachelor’s degree in Pharmacy and a Master’s degree in Pharmaceutics.
Follow Prasad on Twitter: @PPrasad_DRG